[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

The global gRNA (guide RNA) market is projected to grow from USD 518 million in 2024 to USD 2,950 million by 2034, representing a 19% CAGR. Growth is driven by increasing cancer research, infectious disease prevalence, technological innovation, and expanding applications in genome editing, functional genomics, diagnostics, cell & gene therapy, and agricultural biotechnology. Key market players include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, and others. Strategic partnerships and rising adoption of CRISPR technology in agriculture are major growth catalysts.

08/06/2026, 5:30 PM • GlobeNewswire

AI Disruption Reshapes Bioinformatics: Record Investment and Breakthrough Tools Signal a New Era for Drug Discovery and Precision Medicine

Artificial intelligence is fundamentally restructuring bioinformatics, compressing drug discovery timelines and attracting billions in venture capital. AI tools like AlphaFold and generative biology platforms are delivering measurable ROI, with companies achieving 99% cost reductions in drug discovery. North America leads adoption, supported by federal programs and substantial R&D investments from established life sciences players.

08/06/2026, 10:52 AM • GlobeNewswire

Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS Insider

The global mass spectrometry market is valued at $6.68 billion in 2025 and is projected to reach $14.09 billion by 2035, growing at a CAGR of 7.74%. Growth is driven by pharmaceutical manufacturing, omics research, clinical diagnostics, and precision medicine adoption. North America leads the market while Asia Pacific records the fastest growth at 9.12% CAGR.

07/17/2026, 6:56 AM • GlobeNewswire

Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate

The global cancer biomarkers market is valued at USD 28.25 billion in 2026 and is projected to reach USD 54.48 billion by 2032, expanding at an 11.6% CAGR. Growth is driven by rising cancer incidence, technological advances, adoption of precision medicine, and liquid biopsy techniques. Omics technologies and breast cancer diagnostics lead segment growth, while Asia-Pacific emerges as the fastest-growing region. Key players include Roche, Thermo Fisher, Illumina, and Agilent Technologies.

07/17/2026, 6:44 AM • GlobeNewswire

Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand

The global oligonucleotide contract development and manufacturing organization (CDMO) market is experiencing strong growth driven by expanding RNA-targeted medicine pipelines, increased outsourcing of complex synthesis and manufacturing, and rising demand for precision medicine. The market is projected to grow at a 21.81% CAGR through 2031, with contract manufacturing leading at 51.68% market share in 2025. Antisense oligonucleotides dominate at 58.23% revenue, while siRNA is the fastest-growing segment at 23.25% CAGR. Asia-Pacific is the fastest-growing region at 24.56% CAGR, driven by capacity expansion in China, South Korea, and Japan.

07/15/2026, 4:10 AM • GlobeNewswire

Molecular Biology Enzymes, Reagents and Kits Market Size Worth USD 70.85 Billion by 2035 | SNS Insider

The global molecular biology enzymes, reagents and kits market is projected to grow from USD 27.69 billion in 2025 to USD 70.85 billion by 2035, with a CAGR of 9.68%. Growth is driven by increasing adoption of precision medicine, molecular diagnostics, genomics research, and biotechnology R&D. The US market is expected to reach $23.54 billion and Europe $19.32 billion by 2035, with Asia-Pacific showing the fastest growth.

07/03/2026, 6:48 AM • GlobeNewswire

Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider

The global Oxidative Stress Assay Market is projected to grow at a CAGR of 9.53% from 2026 to 2035, driven by rising chronic disease prevalence, pharmaceutical R&D investments, and advancements in biomarker diagnostics. North America leads with 38.52% market share, while Asia-Pacific is expected to show the highest growth rate at 10.55%. ELISA technology dominates with 39% market share, and cancer research accounts for 33% of revenue.

06/28/2026, 10:30 PM • GlobeNewswire

Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™

The global LIMS market is projected to grow from USD 2.88 billion in 2025 to USD 5.19 billion by 2030, with a CAGR of 12.5%. Growth is driven by increasing demand for laboratory automation, regulatory compliance, cloud-based solutions, and AI integration. North America leads the market, while large enterprises dominate adoption. Key challenges include high maintenance costs and system integration complexities.

06/26/2026, 11:00 AM • GlobeNewswire

Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global laboratory equipment services market is projected to grow from USD 28.94 billion in 2025 to USD 62.83 billion by 2035, at a CAGR of 8%. Growth is driven by increased R&D investments in life sciences, stricter regulatory compliance requirements, expansion of biopharma facilities, and adoption of IoT-enhanced predictive maintenance technologies. Repair and maintenance services represent the largest market segment, with North America dominating and Asia Pacific showing the fastest growth.

06/24/2026, 3:30 PM • GlobeNewswire

Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global automated liquid handling systems market is valued at USD 2.7 billion in 2025 and is projected to reach USD 6.9 billion by 2035, growing at a CAGR of 9.8%. Growth is driven by increasing pharmaceutical R&D, clinical trials, technological advancements, and demand for automation in diagnostics and molecular testing. Key players include Eppendorf SE, PerkinElmer Inc., Thermo Fisher Scientific Inc., and QIAGEN NV.

06/18/2026, 10:30 PM • GlobeNewswire

Stock Market Today: S&P 500, Dow Futures Inch Up As US-Iran Deal Awaits Trump Approval — Dell, Agilent, Hewlett Packard Enterprise In Focus

U.S. stock futures edged up on Friday as investors monitored Iran ceasefire developments awaiting Trump approval. Major indexes posted modest gains with healthcare, IT, and consumer discretionary leading. Dell surged nearly 40% on strong earnings, while Agilent and Hewlett Packard Enterprise also gained. Costco reported mixed results with earnings slightly below estimates. The Fed is expected to hold rates steady in June with 98.9% probability.

05/29/2026, 5:39 AM • Benzinga

Why Agilent Technologies Stock Triumphed on Thursday

Agilent Technologies stock surged 17.25% on Thursday following strong Q2 2026 earnings results. The company reported $1.83 billion in revenue (up 10% YoY) and $1.49 per share in adjusted net income (up 14% YoY), beating analyst expectations on both metrics. All three business segments showed growth, with Applied Markets Group leading at 14%. Management raised full-year 2026 guidance for both revenue and adjusted net income.

05/28/2026, 8:07 PM • The Motley Fool

S&P 500 Hits Record Highs, Snowflake Jumps 37% On AI Boom: Stock Market Today

U.S. stocks reached record highs on Thursday following geopolitical news of a ceasefire extension. The S&P 500 advanced 0.5% to 7,557.85, driven by an AI software spending spree. Snowflake surged 37% after beating earnings estimates and announcing a $6 billion AWS partnership expansion. Other notable gainers included Best Buy (+18%), Dollar Tree (+17%), and Agilent Technologies (+17%). However, mixed economic data showed headline PCE inflation at 3.8% while core PCE and consumer spending remained subdued, prompting hawkish Fed commentary.

05/28/2026, 12:58 PM • Benzinga

Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence

The global tissue diagnostics market is projected to grow from USD 6.45 billion in 2025 to USD 9.33 billion by 2031, with a CAGR of 6.35%. Growth is driven by increasing cancer prevalence, rising adoption of precision medicine, advancements in digital pathology and AI-assisted diagnostics, and expanding biomarker-based testing. North America leads the market while Asia-Pacific emerges as a high-growth region.

05/21/2026, 3:37 AM • GlobeNewswire

Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight

The global DNA microarray market is expected to grow from USD 2.5 billion in 2025 to USD 4.7 billion by 2034 at a CAGR of ~7%. Growth is driven by rising demand for genomic research, personalized medicine, early disease diagnosis, and increasing prevalence of cancer and genetic disorders. North America leads the market with 41.39% share, while Asia-Pacific emerges as a key growth contributor.

05/06/2026, 1:00 PM • GlobeNewswire